| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
|
Sin-Chan, Patrick
|
|
2019
|
36 |
1 |
p. 51-67.e7
|
article
|
| 2 |
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
|
Fedoriw, Andrew
|
|
2019
|
36 |
1 |
p. 100-114.e25
|
article
|
| 3 |
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
|
Woolston, Andrew
|
|
2019
|
36 |
1 |
p. 35-50.e9
|
article
|
| 4 |
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
|
Mereiter, Stefan
|
|
2019
|
36 |
1 |
p. 6-16
|
article
|
| 5 |
M-TAP Dance: Targeting PRMT1 and PRMT5 Family Members to Push Cancer Cells Over the Edge
|
Srour, Nivine
|
|
2019
|
36 |
1 |
p. 3-5
|
article
|
| 6 |
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
|
Baccelli, Irène
|
|
2019
|
36 |
1 |
p. 84-99.e8
|
article
|
| 7 |
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies
|
Balanis, Nikolas G.
|
|
2019
|
36 |
1 |
p. 17-34.e7
|
article
|
| 8 |
RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance
|
Lionarons, Daniël A.
|
|
2019
|
36 |
1 |
p. 68-83.e9
|
article
|
| 9 |
The Stromal and Immune Landscape of Colorectal Cancer Progression during Anti-EGFR Therapy
|
Catalano, Irene
|
|
2019
|
36 |
1 |
p. 1-3
|
article
|
Journal description